STOCK TITAN

Revvity (RVTY) CEO Singh logs new grants, option exercise and sales

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Revvity, Inc. insider Prahlad R. Singh, President, Chief Executive Officer and Director, reported multiple equity transactions dated February 4–5, 2026. On February 4, 3,421 shares of common stock were surrendered at $101.13 per share to cover tax withholding on vested restricted stock, and 26,796 time-based restricted stock units were granted, scheduled to vest in three equal annual installments beginning on the first anniversary of grant.

Singh also received a nonqualified stock option for 76,647 shares at an exercise price of $103.395, vesting in three equal annual installments beginning on the first anniversary of grant. On February 5, a previously granted option for 25,525 shares at $92.09 was exercised, and the resulting 25,525 shares of common stock were acquired, followed by market sales totaling 1,307, 12,186, 7,885, 3,079 and 1,068 shares at weighted average prices between $99.02 and $102.52, executed under a Rule 10b5-1 trading plan adopted on February 6, 2025.

After these transactions, Singh reported 120,213 shares of Revvity common stock held directly. An additional 46,583 shares are held indirectly by the Singh Family Trust of 2021 for the sole benefit of his children, with beneficial ownership disclaimed except for any pecuniary interest.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Singh Prahlad R.

(Last) (First) (Middle)
77 4TH AVENUE

(Street)
WALTHAM MA 02451-7567

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REVVITY, INC. [ RVTY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Please See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/04/2026 F 3,421(1)(2) D $101.13 93,417 D
Common Stock 02/04/2026 A 26,796(3) A $0 120,213 D
Common Stock 02/05/2026 M 25,525 A $92.09 145,738 D
Common Stock 02/05/2026 S(4) 1,307 D $99.02(5) 144,431 D
Common Stock 02/05/2026 S(4) 12,186 D $99.55(6) 132,245 D
Common Stock 02/05/2026 S(4) 7,885 D $100.63(7) 124,360 D
Common Stock 02/05/2026 S(4) 3,079 D $101.45(8) 121,281 D
Common Stock 02/05/2026 S(4) 1,068 D $102.52(9) 120,213 D
Common Stock 46,583 I By Singh Family Trust of 2021(10)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
NQ Stock Option (right to buy) $103.395 02/04/2026 A 76,647 (11) 02/04/2033 Common Stock 76,647 $0 76,647 D
NQ Stock Option (right to buy) $92.09 02/05/2026 M 25,525 (12) 02/05/2026 Common Stock 25,525 $0 0 D
Explanation of Responses:
1. The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
2. These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement.
3. Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
4. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025.
5. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
6. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.10 to $100.08. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
7. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.10 to $101.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
8. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $101.12 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
9. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
10. Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
11. This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.
12. This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.
Remarks:
President, Chief Executive Officer and Director
John L. Healy (POA on file) for Prahlad R. Singh 02/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Prahlad R. Singh report in Revvity (RVTY) Form 4?

Prahlad R. Singh reported tax-share withholding, new restricted stock units, a new stock option grant, an option exercise, and several open-market sales. The sales were executed under a pre-established Rule 10b5-1 trading plan dated February 6, 2025, according to the filing’s footnotes.

How many Revvity (RVTY) shares does Prahlad R. Singh own after these transactions?

After the reported transactions, Prahlad R. Singh directly owns 120,213 Revvity common shares. An additional 46,583 shares are held indirectly by the Singh Family Trust of 2021, for his children’s benefit, with Singh disclaiming beneficial ownership except for any pecuniary interest.

What new equity awards did Prahlad R. Singh receive from Revvity (RVTY)?

Singh received 26,796 time-based restricted stock units and a nonqualified stock option for 76,647 shares at an exercise price of $103.395. Both awards are scheduled to vest in three equal annual installments beginning on the first anniversary of their respective grant dates.

What option exercise and share sales did Revvity (RVTY) disclose for Prahlad R. Singh?

On February 5, 2026, Singh exercised an option for 25,525 shares at $92.09 per share and acquired the same number of common shares. He then sold blocks of 1,307, 12,186, 7,885, 3,079 and 1,068 shares at weighted average prices between $99.02 and $102.52.

Why were some Revvity (RVTY) shares surrendered by Prahlad R. Singh on February 4, 2026?

The filing states that 3,421 shares were surrendered to satisfy tax withholding obligations upon vesting of restricted stock originally granted on February 4, 2025. This withholding was required under Singh’s Restricted Stock Unit Agreement with Revvity.

What does the Singh Family Trust of 2021 hold in Revvity (RVTY) shares?

The Singh Family Trust of 2021 holds 46,583 Revvity shares for the sole benefit of Prahlad R. Singh’s children. His spouse serves as trustee, and Singh disclaims beneficial ownership of these shares except for any pecuniary interest, as clarified in the filing’s footnote.
Revvity Inc

NYSE:RVTY

RVTY Rankings

RVTY Latest News

RVTY Latest SEC Filings

RVTY Stock Data

11.28B
113.02M
0.34%
100.5%
5.26%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
WALTHAM